Mark Lappe, Chief Executive Officer at Inhibrx, Inc. (INBX), sold 51,879 shares at $29.92 ($1.5M) on 2022-10-17, disclosed to the SEC on 2022-10-18.
Open-market sale of $1.5M INBX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.66 | 8,981 | $257K | 16.8% |
| 2 | $28.66 | 8,981 | $257K | 16.8% |
| 3 | $29.92 | 14,006 | $419K | 27.3% |
| 4 | $29.92 | 14,006 | $419K | 27.3% |
| 5 | $30.81 | 2,892 | $89K | 5.8% |
| 6 | $30.81 | 2,892 |
| $89K |
| 5.8% |
| 7 | $31.51 | 121 | $4K | 0.2% |
| Total | $29.59 avg | 51,879 | $1.5M | 100% |
| Filing → |
| INBX | BUY | 2024-09-10 | $671K | — | Filing → |
| INBX | BUY | 2024-09-03 | $913K | — | Filing → |
| INBX | BUY | 2024-08-22 | $1.0M | — | Filing → |